Structure-based virtual screening, molecular docking, molecular dynamics simulation and MM/PBSA calculations towards identification of steroidal and non-steroidal selective glucocorticoid receptor modulators

References

• Ahmad, I., Jadhav, H., Shinde, Y., Jagtap, V., Girase, R., & Patel, H. (2021). Optimizing Bedaquiline for cardiotoxicity by structure based virtual screening, DFT analysis and molecular dynamic simulation studies to identify selective MDR-TB inhibitors. In Silico Pharmacology, 9(1), 1–15. https://doi.org/10.1007/s40203-021-00086-x
   PubMedGoogle Scholar
• Alan, I. S., & Alan, B. (2018). Side effects of glucocorticoids. Pharmacokinetics and Adverse Effects of Drugs-Mechanisms and Risks Factors. London: IntechOpen. http://dx.doi.org/10.5772/intechopen.74189.
   Google Scholar
• Bruno, N. E., Nwachukwu, J. C., Srinivasan, S., Nettles, C. C., Izard, T., Jin, Z., Nowak, J., Cameron, M. D., Boregowda, S. V., Phinney, D. G., Elemento, O., Liu, X., Ortlund, E. A., Houtman, R., Stavreva, D. A., Hager, G. L., Kamenecka, T. M., Kojetin, D. J., & Nettles, K. W. (2021). Chemical systems biology reveals mechanisms of glucocorticoid receptor signaling. Nature Chemical Biology, 17(3), 307–316. https://doi.org/10.1038/s41589-020-00719-w
   PubMed Web of Science ®Google Scholar
• Coghlan, M. J., Kym, P. R., Elmore, S. W., Wang, A. X., Luly, J. R., Wilcox, D., Stashko, M., Lin, C. W., Miner, J., Tyree, C., Nakane, M., Jacobson, P., & Lane, B. C. (2001). Synthesis and characterization of non-steroidal ligands for the glucocorticoid receptor: Selective quinoline derivatives with prednisolone-equivalent functional activity. Journal of Medicinal Chemistry, 44(18), 2879–2885. https://doi.org/10.1021/jm010228c
   PubMed Web of Science ®Google Scholar
• Edman, K., Ahlgren, R., Bengtsson, M., Bladh, H., Bäckström, S., Dahmén, J., Henriksson, K., Hillertz, P., Hulikal, V., Jerre, A., Kinchin, L., Kåse, C., Lepistö, M., Mile, I., Nilsson, S., Smailagic, A., Taylor, J., Tjörnebo, A., Wissler, L., & Hansson, T. (2014). The discovery of potent and selective non-steroidal glucocorticoid receptor modulators, suitable for inhalation. Bioorganic & Medicinal Chemistry Letters, 24(11), 2571–2577. https://doi.org/10.1016/j.bmcl.2014.03.070
   PubMed Web of Science ®Google Scholar
• Frew, A. J. (2019). Glucocorticoids. Clinical Immunology, 1165–1175.e.1. https://doi.org/10.1016/B978-0-7020-6896-6.00086-7
   Google Scholar
• Genheden, S., & Ryde, U. (2015). The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opinion on Drug Discovery, 10(5), 449–461. https://doi.org/10.1517/17460441.2015.1032936
   PubMed Web of Science ®Google Scholar
• Ghislat, G., Rahman, T., & Ballester, P. J. (2021). Recent progress on the prospective application of machine learning to structure-based virtual screening. Current Opinion in Chemical Biology, 65, 28–34. https://doi.org/10.1016/j.cbpa.2021.04.009
   PubMed Web of Science ®Google Scholar
• Guvench, O., & MacKerell, A. D. (2008). Comparison of protein force fields for molecular dynamics simulations. Molecular Modeling of Proteins, 443, 63–88.
   Google Scholar
• Hemmerling, M., Nilsson, S., Edman, K., Eirefelt, S., Russell, W., Hendrickx, R., Johnsson, E., Kärrman Mårdh, C., Berger, M., Rehwinkel, H., Abrahamsson, A., Dahmén, J., Eriksson, A. R., Gabos, B., Henriksson, K., Hossain, N., Ivanova, S., Jansson, A.-H., Jensen, T. J., … Hansson, T. (2017). Selective nonsteroidal glucocorticoid receptor modulators for the inhaled treatment of pulmonary diseases. Journal of Medicinal Chemistry, 60(20), 8591–8605. https://doi.org/10.1021/acs.jmedchem.7b01215
   PubMed Web of Science ®Google Scholar
• Hu, X., Pang, J., Zhang, J., Shen, C., Chai, X., Wang, E., Chen, H., Wang, X., Duan, M., Fu, W., Xu, L., Kang, Y., Li, D., Xia, H., & Hou, T. (2022). Discovery of novel GR ligands toward druggable GR antagonist conformations identified by MD simulations and Markov state model analysis. Advanced Science, 9(3), 2102435. https://doi.org/10.1002/advs.202102435
   Web of Science ®Google Scholar
• Huey, R., Morris, G. M., & Forli, S. (2012). Using AutoDock 4 and AutoDock vina with AutoDockTools: A tutorial. The Scripps Research Institute Molecular Graphics Laboratory, 10550, 92037.
   Google Scholar
• Irwin, J. J., & Shoichet, B. K. (2005). ZINC − a free database of commercially available compounds for virtual screening. Journal of Chemical Information and Modeling, 45(1), 177–182. https://doi.org/10.1021/ci049714+
   PubMed Web of Science ®Google Scholar
• Karra, A., Konstantinou, M., Tzortziou, M., Tsialtas, I., Kalousi, F., Garagounis, C., Hayes, J., & Psarra, A.-M. (2018). Potential dissociative glucocorticoid receptor activity for protopanaxadiol and protopanaxatriol. International Journal of Molecular Sciences, 20(1), 94. https://doi.org/10.3390/ijms20010094
   PubMed Web of Science ®Google Scholar
• Krüger, D. M., & Evers, A. (2010). Comparison of structure‐and ligand‐based virtual screening protocols considering hit list complementarity and enrichment factors. ChemMedChem, 5(1), 148–158. https://doi.org/10.1002/cmdc.200900314
   PubMed Web of Science ®Google Scholar
• Lesovaya, E., Yemelyanov, A., Swart, A. C., Swart, P., Haegeman, G., & Budunova, I. (2015). Discovery of Compound A–a selective activator of the glucocorticoid receptor with anti-inflammatory and anti-cancer activity. Oncotarget, 6(31), 30730–30744. https://doi.org/10.18632/oncotarget.5078
   PubMedGoogle Scholar
• Loschwitz, J., Jäckering, A., Keutmann, M., Olagunju, M., Olubiyi, O. O., & Strodel, B. (2021). Dataset of AMBER force field parameters of drugs, natural products and steroids for simulations using GROMACS. Data in Brief, 35, 106948. https://doi.org/10.1016/j.dib.2021.106948
   PubMed Web of Science ®Google Scholar
• McMaster, A., & Ray, D. W. (2007). Modelling the glucocorticoid receptor and producing therapeutic agents with anti‐inflammatory effects but reduced side‐effects. Experimental Physiology, 92(2), 299–309. https://doi.org/10.1113/expphysiol.2006.036194
   PubMed Web of Science ®Google Scholar
• Metin, R., & Akten, E. D. (2021). Drug repositioning to propose alternative modulators for glucocorticoid receptor through structure-based virtual screening. Journal of Biomolecular Structure and Dynamics, 39(1), 1–16. https://doi.org/10.1080/07391102.2021.1960608
   PubMedGoogle Scholar
• Muegge, I., & Rarey, M. (2001). Small molecule docking and score. Reviews in computational chemistry, 17, 1–60, Wiley J. Sons Inc. https://doi.org/10.1002/0471224413.ch1
   Google Scholar
• Onnis, V., Kinsella, G. K., Carta, G., Fayne, D., & Lloyd, D. G. (2009). Rational ligand-based virtual screening and structure–activity relationship studies in the ligand-binding domain of the glucocorticoid receptor-α. Future Medicinal Chemistry, 1(3), 483–499. https://doi.org/10.4155/fmc.09.39
   PubMed Web of Science ®Google Scholar
• Onnis, V., Kinsella, G. K., Carta, G., Jagoe, W. N., Price, T., Williams, D. C., Fayne, D., & Lloyd, D. G. (2010). Virtual screening for the identification of novel nonsteroidal glucocorticoid modulators. Journal of Medicinal Chemistry, 53(8), 3065–3074. https://doi.org/10.1021/jm901452y
   PubMed Web of Science ®Google Scholar
• Ornnork, N., Kiriwan, D., Lirdprapamongkol, K., Choowongkomon, K., Svasti, J., & Eurtivong, C. (2020). Molecular dynamics, MM/PBSA and in vitro validation of a novel quinazoline-based EGFR tyrosine kinase inhibitor identified using structure-based in silico screening. Journal of Molecular Graphics & Modelling, 99, 107639. https://doi.org/10.1016/j.jmgm.2020.107639
   PubMed Web of Science ®Google Scholar
• Panettieri, R. A., Schaafsma, D., Amrani, Y., Koziol-White, C., Ostrom, R., & Tliba, O. (2019). Non-genomic effects of glucocorticoids: An updated view. Trends in Pharmacological Sciences, 40(1), 38–49. https://doi.org/10.1016/j.tips.2018.11.002
   PubMed Web of Science ®Google Scholar
• Pang, J-P., Hu, X-P., Wang, Y-X., Liao, J-N., Chai, X., Wang, X-W., Shen, C., Wang, J-J., Zhang, L-L., Wang, X-Y., Zhu, F., Weng, Q-J., Xu, L., Hou, T-J., & Li, D. (2022). Discovery of a novel nonsteroidal selective glucocorticoid receptor modulator by virtual screening and bioassays. Acta Pharmacologica Sinica, 43(9), 2429–2438. https://doi.org/10.1038/s41401-021-00855-6
   PubMed Web of Science ®Google Scholar
• Potamitis, C., Siakouli, D., Papavasileiou, K. D., Boulaka, A., Ganou, V., Roussaki, M., Calogeropoulou, T., Zoumpoulakis, P., Alexis, M. N., Zervou, M., & Mitsiou, D. J. (2019). Discovery of new non-steroidal selective glucocorticoid receptor agonists. The Journal of Steroid Biochemistry and Molecular Biology, 186, 142–153. https://doi.org/10.1016/j.jsbmb.2018.10.007
   PubMed Web of Science ®Google Scholar
• Quatrini, L., & Ugolini, S. (2021). New insights into the cell-and tissue-specificity of glucocorticoid actions. Cellular & Molecular Immunology, 18(2), 269–278. https://doi.org/10.1038/s41423-020-00526-2
   PubMed Web of Science ®Google Scholar
• Ranjbar, S., Mohammadabadi Kamarei, M., Sakhteman, A., & Khoshneviszadeh, M. (2019). Discovery of potential natural dipeptidyl peptidase-4 inhibitors for type-2 diabetes treatment via structure-based virtual screening. Trends in Pharmaceutical Sciences, 5(3), 137–144.
   Google Scholar
• Ray, N. C., Clark, R. D., Clark, D. E., Williams, K., Hickin, H. G., Crackett, P. H., Dyke, H. J., Lockey, P. M., Wong, M., Devos, R., White, A., & Belanoff, J. K. (2007). Discovery and optimization of novel, non-steroidal glucocorticoid receptor modulators. Bioorganic & Medicinal Chemistry Letters, 17(17), 4901–4905. https://doi.org/10.1016/j.bmcl.2007.06.036
   PubMed Web of Science ®Google Scholar
• Schäcke, H., Schottelius, A., Döcke, W.-D., Strehlke, P., Jaroch, S., Schmees, N., Rehwinkel, H., Hennekes, H., & Asadullah, K. (2004). Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects. Proceedings of the National Academy of Sciences of the United States of America, 101(1), 227–232. https://doi.org/10.1073/pnas.0300372101
   PubMed Web of Science ®Google Scholar
• Scheschowitsch, K., Leite, J. A., & Assreuy, J. (2017). New insights in glucocorticoid receptor signaling–more than just a ligand binding receptor. Frontiers in Endocrinology, 8, 16. https://doi.org/10.3389/fendo.2017.00016
   PubMed Web of Science ®Google Scholar
• Shoichet, B. K. (2004). Virtual screening of chemical libraries. Nature, 432(7019), 862–865. https://doi.org/10.1038/nature03197
   PubMed Web of Science ®Google Scholar
• Shukla, R., & Tripathi, T. (2021). Molecular dynamics simulation in drug discovery: Opportunities and challenges. Innovations and Implementations of Computer Aided Drug Discovery Strategies in Rational Drug Design. Singapore: Springer. https://doi.org/10.1007/978-981-15-8936-2_12.
   Google Scholar
• Sisakht, M., Solhjoo, A., Mahmoodzadeh, A., Fathalipour, M., Kabiri, M., & Sakhteman, A. (2021). Potential inhibitors of the main protease of SARS-CoV-2 and modulators of arachidonic acid pathway: Non-steroidal anti-inflammatory drugs against COVID-19. Computers in Biology and Medicine, 136, 104686. https://doi.org/10.1016/j.compbiomed.2021.104686
   PubMed Web of Science ®Google Scholar
• Soulère, L., Barbier, T., & Queneau, Y. (2021). Docking-based virtual screening studies aiming at the covalent inhibition of SARS-CoV-2 MPro by targeting the cysteine 145. Computational Biology and Chemistry, 92, 107463. https://doi.org/10.1016/j.compbiolchem.2021.107463
   PubMed Web of Science ®Google Scholar
• Takahashi, H., Bekkali, Y., Capolino, A. J., Gilmore, T., Goldrick, S. E., Kaplita, P. V., Liu, L., Nelson, R. M., Terenzio, D., Wang, J., Zuvela-Jelaska, L., Proudfoot, J., Nabozny, G., & Thomson, D. (2007). Discovery and SAR study of novel dihydroquinoline-containing glucocorticoid receptor agonists. Bioorganic & Medicinal Chemistry Letters, 17(18), 5091–5095. https://doi.org/10.1016/j.bmcl.2007.07.021
   PubMed Web of Science ®Google Scholar
• Takahashi, H., Razavi, H., & Thomson, D. (2008). Recent progress in the discovery of novel glucocorticoid receptor modulators. Current Topics in Medicinal Chemistry, 8(6), 521–530. https://doi.org/10.2174/156802608783955737
   PubMed Web of Science ®Google Scholar
• Thakral, S., Narang, R., Kumar, M., & Singh, V. (2020). Synthesis, molecular docking and molecular dynamic simulation studies of 2-chloro-5-[(4-chlorophenyl) sulfamoyl]-N-(alkyl/aryl)-4-nitrobenzamide derivatives as antidiabetic agents. BMC Chemistry, 14(1), 1–16. https://doi.org/10.1186/s13065-020-00703-4
   PubMed Web of Science ®Google Scholar
• Tiwari, G., Chauhan, M. S., & Sharma, D. (2022). Systematic in silico studies of corticosteroids and its binding affinities with glucocorticoid receptor for Covid-19 treatment: Ab-initio, molecular docking and MD simulation studies. Polycyclic Aromatic Compounds, 40(1), 1–16. https://doi.org/10.1080/10406638.2022.2092878
   Google Scholar
• Uings, I. J., Needham, D., Matthews, J., Haase, M., Austin, R., Angell, D., Leavens, K., Holt, J., Biggadike, K., & Farrow, S. N. (2013). Discovery of GW 870086: A potent anti‐inflammatory steroid with a unique pharmacological profile. British Journal of Pharmacology, 169(6), 1389–1403. https://doi.org/10.1111/bph.12232
   PubMed Web of Science ®Google Scholar
• Van Der Spoel, D., Lindahl, E., Hess, B., Groenhof, G., Mark, A. E., & Berendsen, H. J. (2005). GROMACS: Fast, flexible, and free. Journal of Computational Chemistry, 26(16), 1701–1718. https://doi.org/10.1002/jcc.20291
   PubMed Web of Science ®Google Scholar
• Van Paassen, J., Vos, J. S., Hoekstra, E. M., Neumann, K. M., Boot, P. C., & Arbous, S. M. (2020). Corticosteroid use in COVID-19 patients: A systematic review and meta-analysis on clinical outcomes. Critical Care, 24(1), 1–22. https://doi.org/10.1186/s13054-020-03400-9
   PubMed Web of Science ®Google Scholar
• Varela‐Rial, A., Majewski, M., & De Fabritiis, G. (2022). Structure based virtual screening: Fast and slow. Wiley Interdisciplinary Reviews: Computational Molecular Science, 12(2), e1544.
   Web of Science ®Google Scholar
• Vázquez, J., López, M., Gibert, E., Herrero, E., & Luque, F. J. (2020). Merging ligand-based and structure-based methods in drug discovery: An overview of combined virtual screening approaches. Molecules, 25(20), 4723. https://doi.org/10.3390/molecules25204723
   PubMed Web of Science ®Google Scholar
• Wang, E., Sun, H., Wang, J., Wang, Z., Liu, H., Zhang, J. Z. H., & Hou, T. (2019). End-point binding free energy calculation with MM/PBSA and MM/GBSA: Strategies and applications in drug design. Chemical Reviews, 119(16), 9478–9508. https://doi.org/10.1021/acs.chemrev.9b00055
   PubMed Web of Science ®Google Scholar
• Wang, J., Yang, W., Chen, P., Guo, J., Liu, R., Wen, P., Li, K., Lu, Y., Ma, T., Li, X., Qin, S., Zhang, Y., & Wang, Y. (2021). The proportion and effect of corticosteroid therapy in patients with COVID-19 infection: A systematic review and meta-analysis. PLoS One, 16(4), e0249481. https://doi.org/10.1371/journal.pone.0249481
   PubMed Web of Science ®Google Scholar
• Williams, D. M. (2018). Clinical pharmacology of corticosteroids. Respiratory Care, 63(6), 655–670. https://doi.org/10.4187/respcare.06314
   PubMed Web of Science ®Google Scholar
• Xu, D., Xue, G., Peng, B., Feng, Z., Lu, H., & Gong, L. (2020). High-throughput docking and molecular dynamics simulations towards the identification of potential inhibitors against human coagulation factor XIIa. Computational and Mathematical Methods in Medicine, 2020, 2852051. https://doi.org/10.1155/2020/2852051
   PubMed Web of Science ®Google Scholar
• Yang, M., Chen, J., & Wei, W. (2021). Dimerization of glucocorticoid receptors and its role in inflammation and immune responses. Pharmacological Research, 166, 105334. https://doi.org/10.1016/j.phrs.2020.105334
   PubMed Web of Science ®Google Scholar
• Zhang, T., Liang, Y., & Zhang, J. (2020). Natural and synthetic compounds as dissociated agonists of glucocorticoid receptor. Pharmacological Research, 156, 104802. https://doi.org/10.1016/j.phrs.2020.104802
   PubMed Web of Science ®Google Scholar